Drug Reference

Ubrogepant

Calcitonin gene-related peptide (CGRP) antagonists

Fact box

Therapeutic class: Calcitonin gene-related peptide (CGRP) antagonists
Action class: Calcitonin Gene-related Peptide Receptor Antagonist
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonists
Habit forming: No

Brand names

Ubrelvy

Available as

100 MG · Oral Tablet50 MG · Oral Tablet

No structured FDA label was available. Use the authoritative links below.

Current FDA labels (DailyMed)

UBRELVY (UBROGEPANT) TABLET [SPORTPHARM LLC]
UBRELVY (UBROGEPANT) TABLET [ALLERGAN, INC.]

4 marketed products on record (RxNorm)

Authoritative sources

DailyMed — current FDA labeling →
LactMed — breastfeeding safety (NLM) →
MedlinePlus — plain-language drug info →
RxNorm (NLM) →

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.